ACCENDRA HEALTH INC/VA/ — Form 8-K
Filed November 3, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
Perry A. Bernocchi, Executive Vice President and Chief Operating Officer, transitions effective November 1, 2026, to Strategic Advisor to the CEO through December 31, 2026 (or earlier separation). During transition, Bernocchi retains base salary, 2026 Annual Incentive Program eligibility, and benefits. Upon separation, he receives severance under the Officer Severance Policy (or CIC Severance Agreement if triggered by Change in Control within 90 days before/after) and will be engaged as consultant for competitive bidding process. No dollar amounts or specific equity details disclosed.
Why this rating
Leadership transition is material governance event but no financial magnitude disclosed. COO departure is real but orderly transition plan and retention through year-end limits immediate disruption risk.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.